ImmunityBio, Inc. (IBRX)
NASDAQ·Healthcare·Biotechnology
$8.65
—
Mkt Cap $8.81B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (6 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+38.8%
Consensus $12.00 vs current $8.65
NASDAQ·Healthcare·Biotechnology
$8.65
—
Mkt Cap $8.81B
Buy
6
Hold
0
Sell
0
Price Target (6 analysts)
$12.00
Range $12.00 – $12.00
+38.8%
Consensus $12.00 vs current $8.65